ORAL VACCINES MARKET ANALYSIS

Oral Vaccines MarketSize and Trends

Global Oral Vaccines Market Drivers

Rising incidences of infections such as cholera, tuberculosis, and others are expected to propel growth of the oral vaccine market over the forecast period. For instance, according to the World Health Organization (WHO), 2019, around 1.3 million to 4.0 million cases of cholera and approximately 10 million cases of tuberculosis were reported globally in the year 2018. 

Moreover, increasing government support towards new product approvals are expected to drive the oral vaccines market growth. For instance, in October 2018, Sanofi Pasteur received the prequalification status from the World Health Organization (WHO) for its inactivated Polio Vaccine (IPV), ShanIPV. The prequalification program ensures that the vaccines are safe and effective for the immunization programs. The prequalification status qualifies the vaccine ShanIPV for purchase by the agencies of the United Nations for various immunization programs.